Investment analysts at StockNews.com started coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock.
Onconova Therapeutics Stock Down 0.5 %
Shares of ONTX opened at $1.00 on Wednesday. The business’s 50 day moving average is $0.82 and its two-hundred day moving average is $0.74. Onconova Therapeutics has a 52-week low of $0.55 and a 52-week high of $1.45. The firm has a market cap of $20.90 million, a price-to-earnings ratio of -1.09 and a beta of 1.38.
About Onconova Therapeutics
See Also
- Five stocks we like better than Onconova Therapeutics
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Charles Schwab Fortifies its Uptrend on EPS Beat
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Compound Interest and Why It Matters When Investing
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Onconova Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Onconova Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.